English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: Impact of alcohol deterrents on outcome

Krampe, H., Stawicki, S., Wagner, T., Bartels, C., Aust, C., Rüther, E., et al. (2006). Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: Impact of alcohol deterrents on outcome. Alcoholism-Clinical and Experimental Research, 30(1), 86-95. doi:10.1111/j.1530-0277.2006.00013.x.

Item is

Files

show Files
hide Files
:
Krampe_06.pdf (Any fulltext), 316KB
 
File Permalink:
-
Name:
Krampe_06.pdf
Description:
-
OA-Status:
Visibility:
Restricted (UNKNOWN id 315; )
MIME-Type / Checksum:
application/pdf
Technical Metadata:
Copyright Date:
-
Copyright Info:
eDoc_access: MPG
License:
-

Locators

show

Creators

show
hide
 Creators:
Krampe, Henning1, Author           
Stawicki, Sabina1, Author           
Wagner, Thilo1, Author           
Bartels, Claudia1, Author           
Aust, Carlotta1, Author           
Rüther, Eckart, Author
Poser, Wolfgang, Author
Ehrenreich, Hannelore1, Author           
Affiliations:
1Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society, ou_2173651              

Content

show
hide
Free keywords: calcium carbimide; chronic alcohol dependence; alcohol deterrents; disulfiram; long-term treatment; outpatient alcoholism treatment DISULFIRAM TREATMENT; CLIENT HETEROGENEITY; COST-EFFECTIVENESS; DRINKING OUTCOMES; BEHAVIOR-THERAPY; EFFICACY; APPROXIMATION; DISORDERS; ABUSE; TRIAL
 Abstract: Objective: (1) To perform a 9-year study of abstinence, lapse, and relapse in 180 chronic alcoholic patients, participants of the Outpatient Longterm Intensive Therapy for Alcoholics (OLITA); (2) To investigate the role of supervised alcohol deterrents (AD) in relapse prevention and as an adjunct for maintenance of long-term abstinence. Method: This prospective open treatment study evaluates the long-term course of drinking outcomes and AD use of 180 chronic alcoholics consecutively admitted from 1993 to 2002. Subsamples are compared for (1) sham-AD versus verum-AD (disulfiram/calcium carbimide), (2) coped lapses versus finally detrimental lapses versus malignant relapses, and (3) AD use for 13 to 20 versus > 20 months. Results: In this 9-year study, the cumulative probability of not having relapsed was 0.52, and that of not having consumed any alcohol was 0.26. Despite long-term use, disulfiram/calcium carbimide was well tolerated. Patients on sham-AD (due to contraindications to verum-AD) showed higher cumulative abstinence probability than patients on verum (S = 0.86 vs. S = 0.49, p = 0.03). Detrimental lapses and malignant relapses occurred earlier than successfully coped lapses (p < 0.001); patients with detrimental lapse and with malignant relapse had rewer days of AD intake and less subsequent days without AD than patients with coped lapse (p < 0.001). The cumulative abstinence probability was S = 0.75 for patients with long-term intake compared with S = 0.50 for patients who stopped AD between months 13 and 20 (p < 0.001). Conclusions: An abstinence rate of > 50% in this 9-year study strongly supports the concept of comprehensive, long-term outpatient treatment of alcoholics. Supervised, guided intake of AD, also over extended periods, can be used as a predominantly psychologically acting ingredient of successful alcoholism therapy.

Details

show
hide
Language(s): eng - English
 Dates: 2006-01
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 292210
ISI: 000234721700011
ISI: 000234721700011
DOI: 10.1111/j.1530-0277.2006.00013.x
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Alcoholism-Clinical and Experimental Research
  Alternative Title : Alcoholism
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 30 (1) Sequence Number: - Start / End Page: 86 - 95 Identifier: ISSN: 0145-6008